-
Mashup Score: 2ASCO 2023: Adjuvant Everolimus in Patients with Localized Non-Clear Cell Renal Cell Carcinoma: Subgroup Analysis from the EVEREST Trial - 2 year(s) ago
ASCO 2023, kidney cancer, non-clear cell renal cell carcinoma (nccRCC), Adjuvant Everolimus, kidney cancer survival and recurrence, mTOR inhibitor, chromophobe RCC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 70
A Canadian climber died above Camp III on Mt Everest on May 25, taking the season’s death toll to 12, officials said.
Source: The Himalayan TimesCategories: Cardiologists, Latest HeadlinesTweet-
RT @EverestToday: Canadian dies on #Everest taking death toll to 12, five still missing. More: https://t.co/qOabS3uVNL #Everest70 #Everest2…
-
-
Mashup Score: 24American doctor dies at Camp II on Everest - 2 year(s) ago
An American climber died at Camp II on Mt Everest yesterday, expedition organiser said.
Source: The Himalayan TimesCategories: Cardiologists, Latest HeadlinesTweet-
RT @EverestToday: American doctor dies at Camp II on #Everest. More: https://t.co/L13dM4YLrd #Everest70 #Everest2023 https://t.co/u8w3GSCqAO
-
-
Mashup Score: 5ASCO 2022: EVEREST: Everolimus for Renal Cancer Ensuing Surgical Therapy—A Phase III Study (SWOG S0931) - 3 year(s) ago
ASCO 2022 the results of the EVEREST trial of everolimus as adjuvant therapy for patients with renal cell carcinoma (RCC).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#EVEREST: Everolimus for #RenalCancer ensuing surgical therapy— a phase III study (SWOG S0931). Presented by Christopher Ryan, MD @OHSUKnight. #ASCO22 written coverage by @WallisCJD @UofT > https://t.co/Dtw6KiwLI3 @ASCO @amerseburger https://t.co/E6K1RyONPq
-
-
Mashup Score: 1Wolters Kluwer Health - 4 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: journals.lww.comCategories: Emergency Medicine, Latest HeadlinesTweet-
Why did the #EP climb #Everest? This is not a joke but a planned reality for Mike Paterson, MD, who, when he’s not practicing global medicine and #EM, is scaling the tallest mountains, as Ruth SoRelle, MPH, writes. https://t.co/b1Ohd64Wcy P.S. He made it to the top of Everest! https://t.co/sBtsHBfXsR
-
-
Mashup Score: 1Wolters Kluwer Health - 4 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Emergency Medicine, Latest HeadlinesTweet-
Why did the #EP climb #Everest? This is not a joke but a planned reality for Mike Paterson, MD, who, when he’s not practicing global medicine and #EM, is scaling the tallest mountains, as Ruth SoRelle, MPH, writes. https://t.co/b1Ohd64Wcy P.S. He made it to the top of Everest! https://t.co/BernETch9f
-
-
Mashup Score: 2Melting Mountains: National Geographic: Cell Press - 4 year(s) ago
View the Cell Press article collection from the first phase of the National Geographic and Rolex Perpetual Planet partnership.
Source: www.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
Explore this special collection which offers a 1st look at the science and stories emerging from the @insideNatGeo & @Rolex #PerpetualPlanet #Everest Expedition https://t.co/u6SH7q1ZxW @OneEarth_CP @iScience_CP https://t.co/m5cD8eLnml
-
-
Mashup Score: 3Nepal, China agree Mt. Everest is 8,848.86 meters tall - 4 year(s) ago
Nepal and China have agreed that Mt. Everest is 8,848.86 meters tall, ending a discrepancy between the heights recognized by the two nations that the world’s tallest peak straddles.
Source: Kyodo News+Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @kyodo_english: #Nepal, #China agree Mt. #Everest is 8,848.86 meters tall https://t.co/nfYpRRiohq
-
Adjuvant #Everolimus in patients with localized non-clear cell #RenalCellCarcinoma: subgroup analysis from the #EVEREST trial. Presentation by Shuchi Gulati, MD, MS @ucdavis. #ASCO23 written coverage by @RKSayyid @UofT > https://t.co/wVHDsQfr4c @ASCO https://t.co/KCF1zURrb1